Covered recipient · General Payments record
MELIANA TRINIDAD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2024
$888.03
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $313.89 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $183.79 | 11 |
| Otsuka America Pharmaceutical, Inc. | $38.71 | 2 |
| ACADIA Pharmaceuticals Inc | $30.80 | 2 |
| Novo Nordisk AS | $21.67 | 1 |
| REVANCE THERAPEUTICS, INC. | $20.17 | 1 |
| Lilly USA, LLC | $18.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.56 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243598 | CMS |
| ABBVIE INC. | $19.79 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243600 | CMS |
| ABBVIE INC. | $21.01 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243602 | CMS |
| ABBVIE INC. | $13.67 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243604 | CMS |
| ABBVIE INC. | $22.89 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243606 | CMS |
| ABBVIE INC. | $14.94 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243608 | CMS |
| ABBVIE INC. | $25.51 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243610 | CMS |
| ABBVIE INC. | $19.08 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243612 | CMS |
| ABBVIE INC. | $25.02 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243614 | CMS |
| ABBVIE INC. | $6.44 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243616 | CMS |
| ABBVIE INC. | $1.88 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243618 | CMS |
| ACADIA Pharmaceuticals Inc | $16.62 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147995794 | CMS |
| ACADIA Pharmaceuticals Inc | $14.18 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147995796 | CMS |
| Lilly USA, LLC | $18.75 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135188373 | CMS |
| Novo Nordisk Inc | $21.67 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096760646 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.78 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118995681 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.93 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118995683 | CMS |
| REVANCE THERAPEUTICS, INC. | $20.17 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930847 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.